12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12只醫療保健股票在週三盤前交易中有所波動
Gainers
漲幅者
- Mersana Therapeutics (NASDAQ:MRSN) shares rose 22.7% to $2.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $331.2 million. As per the news, the Q3 earnings report came out today.
- Kairos Pharma (AMEX:KAPA) stock rose 19.74% to $2.46. The market value of their outstanding shares is at $31.5 million.
- Calidi Biotherapeutics (AMEX:CLDI) shares increased by 18.48% to $2.5. The market value of their outstanding shares is at $29.1 million. The company's, Q3 earnings came out yesterday.
- Natera (NASDAQ:NTRA) shares rose 16.66% to $157.64. The company's market cap stands at $19.4 billion. As per the news, the Q3 earnings report came out yesterday.
- Ensysce Biosciences (NASDAQ:ENSC) stock increased by 15.62% to $0.78. The market value of their outstanding shares is at $11.6 million. The company's, Q3 earnings came out yesterday.
- Lexeo Therapeutics (NASDAQ:LXEO) stock increased by 12.61% to $8.66. The company's market cap stands at $286.3 million. The company's, Q3 earnings came out today.
- mersana therapeutics(納斯達克:MRSN)股票在週三的盤前交易中上漲了22.7%,達到了2.7美元。其流通股的市值爲33120萬。據資訊,第三季度業績今天發佈。
- Kairos Pharma(美交所:KAPA)股價上漲了19.74%,達到了2.46美元。其流通股的市值爲3150萬。
- Calidi Biotherapeutics(美交所:CLDI)股票上漲了18.48%,達到了2.5美元。其流通股的市值爲2910萬。公司的第三季度業績昨天發佈。
- natera(納斯達克:NTRA)股票上漲了16.66%,達到了157.64美元。公司的市值爲194億。據資訊,第三季度業績昨天發佈。
- Ensysce Biosciences(納斯達克:ENSC)股票上漲了15.62%,達到了0.78美元。其流通股的市值爲1160萬。公司的第三季度業績昨天發佈。
- Lexeo Therapeutics(納斯達克:LXEO)股票上漲了12.61%,達到了8.66美元。公司的市值爲28630萬。公司的第三季度業績今天發佈。
Losers
輸家
- Syros Pharmaceuticals (NASDAQ:SYRS) shares decreased by 85.6% to $0.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $10.5 million.
- GlucoTrack (NASDAQ:GCTK) stock decreased by 72.24% to $0.44. The market value of their outstanding shares is at $2.5 million.
- Psyence Biomedical (NASDAQ:PBM) stock fell 23.4% to $0.05. The company's market cap stands at $2.9 million.
- CERo Therapeutics Hldgs (NASDAQ:CERO) shares declined by 20.03% to $0.21. The market value of their outstanding shares is at $32.1 million.
- Geovax Labs (NASDAQ:GOVX) shares declined by 20.0% to $2.6. The company's market cap stands at $22.1 million. As per the press release, Q3 earnings came out yesterday.
- Virpax Pharmaceuticals (NASDAQ:VRPX) shares fell 17.6% to $0.51. The market value of their outstanding shares is at $2.4 million.
- syros pharmaceuticals (納斯達克:SYRS) 的股票在週三的盤前交易中下跌了85.6%,降至0.39美元。他們的流通股市值爲1050萬。
- GlucoTrack (納斯達克:GCTK) 的股票下跌了72.24%,降至0.44美元。他們的流通股市值爲250萬。
- Psyence 生物醫藥 (納斯達克:PBM) 的股票下跌了23.4%,降至0.05美元。公司的市值爲290萬。
- CERo Therapeutics Hldgs (納斯達克:CERO) 的股票下跌了20.03%,降至0.21美元。他們的流通股市值爲3210萬。
- geovax labs (納斯達克:GOVX) 的股票下跌了20.0%,降至2.6美元。公司的市值爲2210萬。根據新聞稿,第三季度的業績昨天公佈。
- Virpax Pharmaceuticals (納斯達克:VRPX) 的股票下跌了17.6%,降至0.51美元。他們的流通股市值爲240萬。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成,並由編輯審核。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。